Baldasare Bryan T 4
4 · MERIDIAN BIOSCIENCE INC · Filed Feb 9, 2021
Insider Transaction Report
Form 4
Baldasare Bryan T
Chief Accounting Officer
Transactions
- Exercise/Conversion
Common Stock
2021-02-08$19.56/sh+3,750$73,350→ 62,382 total - Exercise/Conversion
Stock Options (Right to Buy)
2021-02-08−3,750→ 0 totalExercise: $19.56Exp: 2026-03-24→ Common Stock (3,750 underlying) - Sale
Common Stock
2021-02-08$30.00/sh−6,254$187,620→ 56,128 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective September 17, 2020.
- [F2]The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective September 17, 2020.
- [F3]These non-qualified options were awarded under the 2012 Stock Incentive Plan and vested in four equal installments from the date of grant and were fully vested on March 24, 2020.